AntiDop - Training Missions on Nutritional Supplements

Erasmus+ SportCollaborative PartnershipsID: 101184932
EC Contribution
โ‚ฌ400,000
Consortium Size
8 orgs
โ–ถSummary

Doping is a global issue, prevalent across various sports worldwide, implicating athletes from diverse backgrounds, regions or types of sports. Moreover, unintentional violations may be caused by various factors such as lack of knowledge, contaminated supplements, use of medications that contain prohibited substances, lack comprehensive understanding of anti-doping rules, environmental contamination or medical treatments. By focusing on Nutritional Supplements (NS), which promise enhanced performance, faster recovery, improved endurance, better focus and concentration, we see that they come in various forms and contain a multitude of ingredients in diverse combinations and quantities. NS are widely used among athletes (over 82%), but not all are safe. Thus, athletes and their support personnel must make informed decisions considering potential risks taking into account a wide range of factors. AntiDop aims to train Athletes Support Personnel (ASP) comprehensively to prevent intentional or unintentional doping violations. It will cover topics like supplement usage, pharmaceuticals, and dietary plans, promoting informed decision-making. Athletes generally heed the guidance of their ASP and rely on the expertise to optimize their diet, enhance performance and achieve their athletic goals. This is the reason we focus on the training of ASP (coaches, trainers, nutritionists, managers, medical doctors, sports psychologists, parents) to make informed decisions regarding supplement usage, weighing both the potential benefits and risks. The project will develop an eLearning/mLearning platform to offer Massive Open Online Courses to effectively educate ASP utilizing interactive training content (e.g. Serious Games, gamification, simulations) for enhanced engagement. The platform will be validated with ASP representatives in six (6) EU countries in a full year pilot study, and results will be disseminated to an extended list of stakeholders and scientific forums. that is published through this page expresses the views of the project beneficiaries only and it does not represent the views of the European Union or the European Commission. It shall not be deemed to constitute legal or official notice on behalf of the European Union or the European Commission. Neither the European Union nor the European Commission can be held responsible for this content nor the use thereof made by any third parties. Page 2 of 2

Consortium (8)